A new JGP study shows how a disease-causing mutation in RyR2 dramatically alters channel behavior.
The human heart beats more than 2.5 billion times over the course of an average lifetime. The ryanodine receptor type 2 (RyR2) helps regulate these beats, and mutations in this ion channel cause catecholamine-induced polymorphic ventricular tachycardia (CPVT). Uehara et al. describe how one particular disease-causing mutation dramatically affects RyR2 behavior (1) . sensitivity mechanisms induced by this single missense point mutation," says Uehara. Uehara et al. theorize that the lysine at 4750 may help stabilize RyR2's closed conformation by forming salt bridges with nearby charged amino acids-interactions that could be lost upon substitution of a neutral residue such as glutamine. Functional studies are already underway to test this, and Uehara invites collaborations on structural studies to learn more about how K4750Q affects RyR2 activity.
